{"nct_id":"NCT03000257","title":"A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors","status":"COMPLETED","status_verified_date":"2022-04","start_date":"2016-12-14","start_date_type":"ACTUAL","primary_completion_date":"2022-03-29","primary_completion_date_type":"ACTUAL","completion_date":"2022-03-29","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ABBV"]}